|
A Brief Psychological Intervention for Carer Fear of Cancer Progression
RECRUITINGN/ASponsored by University of Aarhus
Actively Recruiting
PhaseN/A
SponsorUniversity of Aarhus
Started2026-06-15
Est. completion2027-02
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07752992
Summary
This study aims to evaluate the feasibility and acceptability of the Conquer Fear Carer Brief, a three-session psychological intervention targeting fear of cancer progression among caregivers of patients with metastatic prostate cancer.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Self-identified caregiver of a patient with metastatic, non-curable cancer * Aged ≥18 years * Score in the clinical range (≥22) on the Fear of Cancer Recurrence Inventory Short Form (FCRI-SF) * Score in the clinical range (\>15) on the Brief Penn State Worry Questionnaire (PSWQ) * Sufficient proficiency in Danish * Able to provide informed consent * Stable or no use of antidepressant or anxiolytic medication (i.e., stable dosage for ≥6 weeks) * Able to participate in online-delivered therapy via a computer with a video camera Exclusion Criteria: * Severe psychiatric conditions (e.g., major depression) that would make participation in the intervention inappropriate * Currently enrolled in psychotherapy or counseling targeting the same problem * Substance abuse or dependence judged to require treatment * Suicide risk requiring immediate psychiatric intervention or hospitalization
Conditions2
CancerFear of Cancer Progression
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity of Aarhus
Started2026-06-15
Est. completion2027-02
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07752992